Jazz Pharmaceuticals plc (JAZZ)

NASDAQ: JAZZ · Real-Time Price · USD

241.46

+0.72 (0.30%)

At close: Sep 21, 2026, 4:00 PM EDT

241.46

0.00 (0.00%)

After-hours: Sep 21, 2026, 4:15 PM EDT

Jazz Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	15,674	10,330	7,445	7,744	10,031	7,831
Market Cap Growth	99.48%	38.75%	-3.86%	-22.80%	28.09%	-14.84%
Enterprise Value	17,884	13,713	11,032	11,945	14,946	13,570
Last Close Price	240.74	170.00	123.15	123.00	159.31	127.40

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	16.45	-	13.29	18.67	-	-
Forward PE	9.56	7.67	5.72	6.29	8.54	8.23
PS Ratio	3.42	2.42	1.83	2.02	2.74	2.53
PB Ratio	3.25	2.39	1.82	2.07	3.25	1.98
P/FCF Ratio	9.90	7.96	5.48	7.25	8.07	10.43
P/OCF Ratio	9.48	7.62	5.33	7.09	7.89	10.06
PEG Ratio	0.17	0.55	0.37	0.50	1.14	0.62

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	3.90	3.21	2.71	3.12	4.08	4.39
EV/EBITDA Ratio	9.32	8.00	7.24	8.21	10.18	13.20
EV/EBIT Ratio	14.85	13.47	12.77	14.63	17.81	28.55
EV/FCF Ratio	11.29	10.57	8.13	11.18	12.03	18.07

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.92	1.26	1.51	1.55	1.89	1.56
Debt / EBITDA Ratio	2.25	3.11	3.97	3.92	3.90	5.84
Debt / FCF Ratio	2.77	4.18	4.54	5.43	4.68	8.22
Net Debt / Equity Ratio	0.46	0.69	0.78	1.12	1.60	1.41
Net Debt / EBITDA Ratio	1.15	1.74	2.08	2.87	3.36	5.43
Net Debt / FCF Ratio	1.39	2.30	2.34	3.90	3.97	7.44
Asset Turnover	0.42	0.36	0.35	0.35	0.32	0.33
Inventory Turnover	0.84	0.79	0.58	0.43	0.30	0.37
Quick Ratio	1.38	1.46	3.57	1.52	1.64	1.43
Current Ratio	1.78	1.86	4.46	2.24	2.79	3.23
Return on Equity (ROE)	22.11%	-8.47%	14.31%	12.16%	-6.35%	-8.65%
Return on Assets (ROA)	6.86%	5.38%	4.61%	4.59%	4.53%	3.15%
Return on Invested Capital (ROIC)	17.17%	13.97%	11.39%	10.25%	9.55%	7.13%
Return on Capital Employed (ROCE)	13.70%	10.80%	7.90%	8.30%	8.50%	4.10%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	5.97%	-3.45%	7.52%	5.36%	-2.23%	-4.21%
FCF Yield	10.10%	12.56%	18.24%	13.79%	12.39%	9.59%
Buyback Yield / Dilution	-5.40%	7.61%	8.41%	-15.23%	-4.77%	-5.62%

SEC Filings: 10-K · 10-Q